+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "RNA"

Antisense and RNAi Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Antisense and RNAi Therapeutics - Global Strategic Business Report

  • Report
  • September 2026
  • 279 Pages
  • Global
From
SNP Genotyping and Analysis - Global Strategic Business Report - Product Thumbnail Image

SNP Genotyping and Analysis - Global Strategic Business Report

  • Report
  • September 2026
  • 297 Pages
  • Global
From
Molecular Weight Markers - Global Strategic Business Report - Product Thumbnail Image

Molecular Weight Markers - Global Strategic Business Report

  • Report
  • September 2026
  • 229 Pages
  • Global
From
DNA and RNA Sample Preparation - Global Strategic Business Report - Product Thumbnail Image

DNA and RNA Sample Preparation - Global Strategic Business Report

  • Report
  • September 2026
  • 179 Pages
  • Global
From
RNA Analysis / Transcriptomics - Global Strategic Business Report - Product Thumbnail Image

RNA Analysis / Transcriptomics - Global Strategic Business Report

  • Report
  • September 2026
  • 504 Pages
  • Global
From
Oligonucleotide Synthesis - Global Strategic Business Report - Product Thumbnail Image

Oligonucleotide Synthesis - Global Strategic Business Report

  • Report
  • September 2026
  • 383 Pages
  • Global
From
Single-Cell Analysis - Global Strategic Business Report - Product Thumbnail Image

Single-Cell Analysis - Global Strategic Business Report

  • Report
  • September 2026
  • 254 Pages
  • Global
From
From
NGS-Based RNA-Sequencing - Global Strategic Business Report - Product Thumbnail Image

NGS-Based RNA-Sequencing - Global Strategic Business Report

  • Report
  • September 2026
  • 220 Pages
  • Global
From
Epigenetics - Global Strategic Business Report - Product Thumbnail Image

Epigenetics - Global Strategic Business Report

  • Report
  • September 2026
  • 427 Pages
  • Global
From
RNA Interference (RNAi) - Global Strategic Business Report - Product Thumbnail Image

RNA Interference (RNAi) - Global Strategic Business Report

  • Report
  • September 2026
  • 178 Pages
  • Global
From
From
CAR T - Cell Therapy - Competitive Landscape, 2026 - Product Thumbnail Image

CAR T - Cell Therapy - Competitive Landscape, 2026

  • Report
  • January 2026
  • 500 Pages
  • Global
From
From
From
RNA Interference Therapy-Competitive Landscape, 2026 - Product Thumbnail Image

RNA Interference Therapy-Competitive Landscape, 2026

  • Report
  • January 2026
  • 220 Pages
  • Global
From
From
From
From
From
Loading Indicator

The RNA market is a subset of the genomics market that focuses on the study of ribonucleic acid (RNA). RNA is a molecule that plays a key role in the regulation of gene expression and is involved in many cellular processes. It is used in a variety of applications, including diagnostics, therapeutics, and research. The RNA market is expected to grow at a steady rate due to the increasing demand for RNA-based products and services. This growth is driven by advances in technology, such as next-generation sequencing, which has enabled the development of more accurate and cost-effective RNA-based products. Additionally, the increasing prevalence of chronic diseases and the need for personalized medicine are expected to drive the growth of the RNA market. Companies in the RNA market include Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, Bio-Rad Laboratories, and F. Hoffmann-La Roche. Show Less Read more